Intravesical BCG therapy has been successfully used
for the treatment of superficial bladder cancer [1, 2]. For BCG therapy
to be effective, the development of an immune response seems to be important,
although the exact mechanism remains to be established . For the initiation
of the immune reaction, several steps during the first interaction of
BCG with the bladder wall have been suggested to be involved....